Epstein-Barr Virus - Infectious Disease and Antimicrobial Agents
Il virus di Epstein - barr (EBV): che cos'è? - Laboratorio Analisi Lepetit
Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011
Long COVID symptoms likely caused by Epstein- | EurekAlert!
Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls | HTML
A scheme of serological response to Epstein-Barr virus (EBV)... | Download Scientific Diagram
T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
Epstein Barr – simptomatologie și tratament – NewsMed.ro
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis | Journal of Neurology, Neurosurgery & Psychiatry
Epstein-Barr Virus (VCA) IgG (CSF) ELISA - VIDIA | MoBiTec Molecular Biotechnology
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
VIRUS EPSTEIN-BARR (EBNA IgG) - Analisi Papagni
Epstein-Barr virus VCA IgG ELISA - IBL International
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma | mSphere
Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. - Abstract - Europe PMC
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells | Science Advances
Test
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus - ScienceDirect
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation - ScienceDirect
